GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MYOD1 | hg19_v2_chr11_+_17741111_17741124 | 0.24 | 3.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_152590946 Show fit | 20.71 |
ENST00000172853.10
|
nebulin |
|
chr11_+_1860200 Show fit | 16.75 |
ENST00000381911.1
|
troponin I type 2 (skeletal, fast) |
|
chrX_-_107018969 Show fit | 16.45 |
ENST00000372383.4
|
TSC22 domain family, member 3 |
|
chr19_-_45826125 Show fit | 15.24 |
ENST00000221476.3
|
creatine kinase, muscle |
|
chr16_+_30387141 Show fit | 14.70 |
ENST00000566955.1
|
myosin light chain, phosphorylatable, fast skeletal muscle |
|
chr9_-_35689900 Show fit | 13.00 |
ENST00000378300.5
ENST00000329305.2 ENST00000360958.2 |
tropomyosin 2 (beta) |
|
chr2_+_220283091 Show fit | 12.32 |
ENST00000373960.3
|
desmin |
|
chr16_+_30383613 Show fit | 12.03 |
ENST00000568749.1
|
myosin light chain, phosphorylatable, fast skeletal muscle |
|
chr11_+_1860682 Show fit | 11.72 |
ENST00000381906.1
|
troponin I type 2 (skeletal, fast) |
|
chr11_+_1860832 Show fit | 11.29 |
ENST00000252898.7
|
troponin I type 2 (skeletal, fast) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 114.8 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
8.2 | 41.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 33.7 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
7.7 | 30.8 | GO:0007525 | somatic muscle development(GO:0007525) |
3.0 | 23.7 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.9 | 20.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.8 | 16.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.0 | 16.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 14.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.7 | 13.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 73.7 | GO:0005861 | troponin complex(GO:0005861) |
1.7 | 62.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
6.9 | 41.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 41.0 | GO:0030018 | Z disc(GO:0030018) |
1.2 | 21.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
2.3 | 18.0 | GO:0035976 | AP1 complex(GO:0035976) |
1.6 | 17.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 12.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 11.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 10.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 119.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.5 | 49.2 | GO:0031014 | troponin T binding(GO:0031014) |
2.9 | 25.9 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 19.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
3.3 | 16.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.2 | 16.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 16.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.9 | 15.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.6 | 10.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.7 | 10.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 20.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 17.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 17.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 15.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 15.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 9.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 7.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 7.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 6.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 5.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 143.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 18.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 14.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 10.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 10.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 9.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 9.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 6.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 6.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 6.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |